Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19INTERNATIONAL IMMUNOPHARMACOLOGYIF4.72022-06-011OAAI
Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial studyBIOMEDICINE & PHARMACOTHERAPYIF7.52022-05-011OAAI
Predictors of the chest CT score in COVID-19 patients: a cross-sectional study (vol 18, 225, 2021)新型冠状病毒肺炎患者胸部CT评分的预测因素: 一项横断面研究 (第18卷,225,2021)VIROLOGY JOURNALIF3.82021-12-062OAAI
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trialPHARMACOLOGICAL REPORTSIF3.82021-11-2746OAAI
Predictors of the chest CT score in COVID-19 patients: a cross-sectional studyVIROLOGY JOURNALIF3.82021-11-1819OAAI
Carnitine for prevention of antituberculosis drug- induced hepatotoxicity: A randomized, clinical trialJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGYIF3.42014-04-2126PREAI
Cyproheptadine for Prevention of Neuropsychiatric Adverse Effects of Efavirenz: A Randomized Clinical TrialAIDS PATIENT CARE AND STDSIF3.82013-03-0114PRE
CD4+Cell Counts in Patients with Different Clinical Manifestations of TuberculosisBRAZILIAN JOURNAL OF INFECTIOUS DISEASESIF2.82008-12-0134OAAI